2Tatemoto K, Hosoya M, Habata Y, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor[J]. Biochem Biophys Res Commun, 1998, 251(2) :471-476.
3Tatemoto K, Takayama K, Zou MX, et al. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism[J]. Regul Pept,2001,99(2/3):87-92.
4Szokodi I, Tavi P, Foldes G, et al. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility [J]. Circ Res,2002,91(5) :434-440.
5Chong KS,Gardner RS, Morton J J, et al. Plasma concentrations of the novel peptide apelin are decreased in patients with ehoronic heart failure[J]. Eur J Heart Fail, 2006,8(4): 355-360.
6Chen MM,Ashley EA,Deng DX,et al. Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction[J]. Circulation, 2003,108(12) : 1432-1439.
7Foldes G, Horkay F, Szokodi I, et al. Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ,in patients with heart failure[J]. Bioehem Biophys Res Commun, 2003,308(3) :480-485.
8Iwanaga Y, Kihara Y, Takenaka H, et al. Down-regulation of cardiac apelin system in hypertrophied and failing hearts: possible role of angiotensin Ⅱ-angiotensin type 1 receptor system[J]. J Mol Cell Cardiol, 2006,41 (5) : 798-806.
二级参考文献7
1Ho KK, Anderson KM, Kannel WB, et al. Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation, 1993,88 : 107-115.
2Willem JR, Karl S. Guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure, European Society of Cardiology. Eur Heart J,2001,22: 1527-1560.
3Vason RS, Larson MG, Benjanin EJ, et al. Congestive heart failure in subject with normal versus reduced left ventricular ejection fraction. J Am Coll Cardiol, 1999,33: 1948-1955.
4Mary MM, Joe F, Peter IL, et al. Systolic function, readmission rates, and survival among consecutively hospitalized patients with congestive heart failure. Am Heart J, 1997,134:728-736.
5McAllister FA, Teo KK, Taher M, et al. Comparison of treatment patients and outcomes in heart failure patients with systolic versus diastolic left ventricular dysfunction [ abstract]. J Am Coll Cardiol, 1997,29s: 64A.
6Ansari M, Alexander M, Tutar A, et al. Incident cases of heart failure in a community cohort: importance and outcomes of patients with preserved systolic function. Am Heart J,2003,146: 115-120.
7Berry C, Hogg K, Norrie J, et al. Heart failure with preserved left ventricular systolic function: a hospital cohort study. Heart,2005, 9:907-913.
